CDMO

Piramal collaborates with BerGenBio to develop leukemia treatment

Read more

Piramal’s Pharma business grows over 10 per cent in FY19

Read more

Piramal Pharma invests $10 million to expand its high potency API capability in US

Read more

‘There will be a shakeout in the CDMO industry’

Read more

Recipharm to acquire Kemwell’s CDMO biz

Read more